
Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis
Author(s) -
Matteo Bellone,
Lorenzo Pradelli,
Rita Tavarozzi,
Marco Ladetto,
Giuliaepoti,
Emanuele Guardalben,
Daniela Ghislieri
Publication year - 2022
Publication title -
farmeconomia/farmeconomia e percorsi terapeutici
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v23i1.1532
Subject(s) - obinutuzumab , medicine , lymphoma , rituximab